215 related articles for article (PubMed ID: 22661469)
1. Preservation of retina ganglion cell function by morphine in a chronic ocular-hypertensive rat model.
Husain S; Abdul Y; Crosson CE
Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):4289-98. PubMed ID: 22661469
[TBL] [Abstract][Full Text] [Related]
2. Delta-opioid agonist SNC-121 protects retinal ganglion cell function in a chronic ocular hypertensive rat model.
Abdul Y; Akhter N; Husain S
Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):1816-28. PubMed ID: 23404122
[TBL] [Abstract][Full Text] [Related]
3. Acetylation preserves retinal ganglion cell structure and function in a chronic model of ocular hypertension.
Alsarraf O; Fan J; Dahrouj M; Chou CJ; Yates PW; Crosson CE
Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7486-93. PubMed ID: 25358731
[TBL] [Abstract][Full Text] [Related]
4. PI3K/Akt Pathway: A Role in δ-Opioid Receptor-Mediated RGC Neuroprotection.
Husain S; Ahmad A; Singh S; Peterseim C; Abdul Y; Nutaitis MJ
Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6489-6499. PubMed ID: 29288267
[TBL] [Abstract][Full Text] [Related]
5. Functional and structural evaluation of lamotrigine treatment in rat models of acute and chronic ocular hypertension.
Sandalon S; Könnecke B; Levkovitch-Verbin H; Simons M; Hein K; Sättler MB; Bähr M; Ofri R
Exp Eye Res; 2013 Oct; 115():47-56. PubMed ID: 23810807
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the cysteinyl leukotriene pathways increases survival of RGCs and reduces microglial activation in ocular hypertension.
Trost A; Motloch K; Koller A; Bruckner D; Runge C; Schroedl F; Bogner B; Kaser-Eichberger A; Strohmaier C; Ladek AM; Preishuber-Pfluegl J; Brunner SM; Aigner L; Reitsamer HA
Exp Eye Res; 2021 Dec; 213():108806. PubMed ID: 34715090
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of a JNK inhibitor against retinal ganglion cell loss induced by acute moderate ocular hypertension.
Sun H; Wang Y; Pang IH; Shen J; Tang X; Li Y; Liu C; Li B
Mol Vis; 2011 Apr; 17():864-75. PubMed ID: 21527996
[TBL] [Abstract][Full Text] [Related]
8. Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension.
McKinnon SJ; Lehman DM; Kerrigan-Baumrind LA; Merges CA; Pease ME; Kerrigan DF; Ransom NL; Tahzib NG; Reitsamer HA; Levkovitch-Verbin H; Quigley HA; Zack DJ
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1077-87. PubMed ID: 11923249
[TBL] [Abstract][Full Text] [Related]
9. Evidence for ceramide induced cytotoxicity in retinal ganglion cells.
Fan J; Liu J; Liu J; Chen C; Koutalos Y; Crosson CE
Exp Eye Res; 2021 Oct; 211():108762. PubMed ID: 34499916
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma.
Jiang C; Moore MJ; Zhang X; Klassen H; Langer R; Young M
Mol Vis; 2007 Sep; 13():1783-92. PubMed ID: 17960131
[TBL] [Abstract][Full Text] [Related]
11. Functional evaluation of retina and optic nerve in the rat model of chronic ocular hypertension.
Grozdanic SD; Kwon YH; Sakaguchi DS; Kardon RH; Sonea IM
Exp Eye Res; 2004 Jul; 79(1):75-83. PubMed ID: 15183102
[TBL] [Abstract][Full Text] [Related]
12. Selective ganglion cell functional loss in rats with experimental glaucoma.
Fortune B; Bui BV; Morrison JC; Johnson EC; Dong J; Cepurna WO; Jia L; Barber S; Cioffi GA
Invest Ophthalmol Vis Sci; 2004 Jun; 45(6):1854-62. PubMed ID: 15161850
[TBL] [Abstract][Full Text] [Related]
13. A mouse model of elevated intraocular pressure: retina and optic nerve findings.
Gross RL; Ji J; Chang P; Pennesi ME; Yang Z; Zhang J; Wu SM
Trans Am Ophthalmol Soc; 2003; 101():163-9; discussion 169-71. PubMed ID: 14971574
[TBL] [Abstract][Full Text] [Related]
14. Pattern electroretinography in a rat model of ocular hypertension: functional evidence for early detection of inner retinal damage.
Ben-Shlomo G; Bakalash S; Lambrou GN; Latour E; Dawson WW; Schwartz M; Ofri R
Exp Eye Res; 2005 Sep; 81(3):340-9. PubMed ID: 16129101
[TBL] [Abstract][Full Text] [Related]
15. Oral administration of a dual ET
Kodati B; McGrady NR; Jefferies HB; Stankowska DL; Krishnamoorthy RR
Mol Vis; 2022; 28():165-177. PubMed ID: 36274816
[TBL] [Abstract][Full Text] [Related]
16. Etanercept, a widely used inhibitor of tumor necrosis factor-α (TNF-α), prevents retinal ganglion cell loss in a rat model of glaucoma.
Roh M; Zhang Y; Murakami Y; Thanos A; Lee SC; Vavvas DG; Benowitz LI; Miller JW
PLoS One; 2012; 7(7):e40065. PubMed ID: 22802951
[TBL] [Abstract][Full Text] [Related]
17. Retinal damage after 3 to 4 months of elevated intraocular pressure in a rat glaucoma model.
Mittag TW; Danias J; Pohorenec G; Yuan HM; Burakgazi E; Chalmers-Redman R; Podos SM; Tatton WG
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3451-9. PubMed ID: 11006238
[TBL] [Abstract][Full Text] [Related]
18. Time-dependent retinal ganglion cell loss, microglial activation and blood-retina-barrier tightness in an acute model of ocular hypertension.
Trost A; Motloch K; Bruckner D; Schroedl F; Bogner B; Kaser-Eichberger A; Runge C; Strohmaier C; Klein B; Aigner L; Reitsamer HA
Exp Eye Res; 2015 Jul; 136():59-71. PubMed ID: 26001526
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma.
Stankowska DL; Minton AZ; Rutledge MA; Mueller BH; Phatak NR; He S; Ma HY; Forster MJ; Yorio T; Krishnamoorthy RR
Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):893-907. PubMed ID: 25587060
[TBL] [Abstract][Full Text] [Related]
20. Retinal ganglion cell loss in a rat ocular hypertension model is sectorial and involves early optic nerve axon loss.
Soto I; Pease ME; Son JL; Shi X; Quigley HA; Marsh-Armstrong N
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):434-41. PubMed ID: 20811062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
